Ultrasound versus biological markers in the evaluation of periportal fibrosis in human Schistosoma mansoni
AUTOR(ES)
Domingues, Ana Lúcia Coutinho, Medeiros, Tibério Batista de, Lopes, Edmundo Pessoa de Almeida
FONTE
Memórias do Instituto Oswaldo Cruz
DATA DE PUBLICAÇÃO
2011-11
RESUMO
In this paper, the authors review the literature and share their experience of the principal biological markers of fibrosis for the evaluation of periportal fibrosis (PPF) caused by mansoni schistosomiasis. These biological markers are compared to diagnostic ultrasound (US) scans as means of grading PPF. We also review procollagen type I and III, collagen type IV, laminin, hyaluronic acid (HA), immunoglobulin G, platelets, aspartate aminotransferase to platelet ratio index (APRI) and gamma-glutamyl transpeptidase as markers of the disease. Although there are several good markers for evaluating PPF and portal hypertension, such as HA, platelets or APRI, none can yet replace US. These markers may, however, be used to identify patients at greater risk of developing advanced disease in endemic areas and determine who will need further care and US studies.
Documentos Relacionados
- Clinical versus ultrasound examination in the evaluation of hepatosplenic schistosomiasis mansoni in endemic areas
- No Evidence for a Major Effect of Tumor Necrosis Factor Alpha Gene Polymorphisms in Periportal Fibrosis Caused by Schistosoma mansoni Infection
- Disagreement between ultrasound and magnetic resonance imaging in the identification of schistosomal periportal fibrosis
- Association of Type 2 Cytokines with Hepatic Fibrosis in Human Schistosoma mansoni Infection
- Low transformation growth factor-β1 production and collagen synthesis correlate with the lack of hepatic periportal fibrosis development in undernourished mice infected with Schistosoma mansoni